TRENDING :  Market Movers  |  Top 50   SPY (0.86%)    JNJ (0.12%)    TSLA (0.22%)    UGAZ (-14.77%)    RLGT (1.68%)    RDFN (0.4%)    OMER (3%)    NVDA (-2.63%)    NNDM (2.59%)    KOPN (4.35%)    HTZ (1.28%)    HTGM (6.66%)    GS (0.83%)    GNC (0.58%)    GDX (0%)    FB (-1.76%)    EWC (1.03%)    DSLV (-3.02%)    CI (1.45%)    CARA (3.19%)    BUZ (0.73%)    BOIL (-8.53%)    BHC (-0.34%)    AU (1.05%)    ASNA (-4.58%)

 TEVA - Teva Pharmaceutical Industries Limited

$16.88 (-0.77%)

Next Earnings

2/7/2019

BMO



Analyst Rating

CompanyAnalyst NamePT ActionActionRatingTargetDate
Morgan StanleyAnnouncesUpgradesOverweight$27.0011/05/18
Bank of AmericaJason GerberryRaisesMaintainsUnderperform$20.0011/02/18
Leerink SwannAmi FadiaUpgradesMarket Perform$0.0010/01/18
BTIG ResearchTim ChiangUpgradesNeutral$0.0009/17/18
Credit SuisseVamil DivanLowersDowngradesNeutral$23.0009/07/18
BarclaysDouglas TsaoRaisesMaintainsEqual-Weight$23.0008/06/18
Morgan StanleyDavid RisingerRaisesMaintainsEqual-Weight$20.0008/03/18
Cantor FitzgeraldLouise ChenRaisesMaintainsNeutral$25.0007/16/18
Wells FargoUpgradesMarket Perform$0.0006/18/18
CitigroupLiav AbrahamRaisesMaintainsBuy$25.0005/31/18
BarclaysDouglas TsaoRaisesMaintainsEqual-Weight$20.0005/24/18
Morgan StanleyDavid RisingerRaisesMaintainsEqual-Weight$0.0005/07/18
Credit SuisseVamil DivanUpgradesOutperform$0.0002/12/18
PiperJaffrayDowngradesUnderweight$0.0002/09/18
BTIG ResearchTim ChiangDowngradesNeutral$0.0001/18/18
MizuhoIrina Rivkind KofflerUpgradesBuy$0.0001/09/18
Wells FargoDowngradesUnderperform$0.0001/05/18
CitigroupLiav AbrahamUpgradesBuy$0.0001/04/18
Leerink SwannAnnouncesInitiates Coverage OnUnderweight$15.0001/02/18

OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $TEVA

TRENDING ARTICLES



Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug

12/18/18
Alkermes Plc ALKS and partner Biogen BIIB announced that they have submitted a new drug application NDA to the FDA for diroximel fumarate BIIB098 a novel oral fumarate being developed for the treatment of relapsing forms of multiple sclerosis MS 160 The NDA submission was

Teva Reports Positive Top-Line Data for Migraine Candidate

12/18/18
Teva Pharmaceutical Industries Ltd TEVA announced positive top line results from the phase IIIb FOCUS study 160 that evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients who previously experienced inadequate responses to two to

3 Value Stocks to Absolutely Love During This Correction

12/18/18
It s been a wild year for the stock market after what was an almost too quiet 2017 Having made it through the previous year without so much as a decline beyond 4 the markets major indexes have undergone two full blown corrections in 2018 And by correction I mean a decline of at

iShares MSCI EAFE ETF Experiences Big Inflow

12/17/18
Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI EAFE ETF Symbol EFA where we have detected an approximate 181 3 million dollar inflow that s a 0 3 increase week over week in outstanding

Teva Reports Positive Topline Phase IIIb Results With Fremanezumab - Quick Facts

12/17/18
Teva Reports Positive Topline Phase IIIb Results With Fremanezumab - Quick Facts

Teva Reports Positive Topline Phase IIIb Results With Fremanezumab - Quick Facts

12/17/18
Teva Reports Positive Topline Phase IIIb Results With Fremanezumab - Quick Facts

Should Warren Buffett — And You — Buy More TEVA Stock Right Now?

12/13/18
InvestorPlace Stock Market News Stock Advice amp Trading Tips The last few years for drug maker Teva Pharmaceuticals NASDAQ TEVA haven t exactly been that wonderful TEVA stock has plunged on a series of mishaps and issues In fact TEVA has fallen

Here's Why Corcept Therapeutics Rose 18.6% in November

12/11/18
What happened Shares of Corcept Therapeutics NASDAQ CORT were up 18 6 in November according to data provided by S amp P Global Market Intelligence after the biotech released promising third quarter earnings results 160 and made progress on its second generation Cushing

Teva (TEVA) Stock Poised to Record Big Gains in 2019?

12/11/18
Shares of Teva Pharmaceutical Industries Limited TEVA have picked up pace this year so far after declining sharply in 2017 Though the stock has declined 2 7 this year it has outperformed its industry s decline of 14 Last year Teva s stock declined a massive 54

MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board

12/11/18
MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board

MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board

12/11/18
MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board

3 Big Stock Charts for Tuesday: Micron Technology, Fortive and Morgan Stanley

12/11/18
InvestorPlace Stock Market News Stock Advice amp Trading Tips For the better part of Monday stocks were in the red Once push came to shove as the closing bell approached though yesterday s move to new multi months lows was negated The S amp P 500 finished at 2637 72

Generic Drugmakers Down on Allegations of Price Fixing

12/11/18
Shares of generic drugmakers took a hit on Monday after allegations related to price fixing of several drugs surfaced in an article published on The Washington Post Shares of all major players in the generic industry plunged following the report Shares of Mylan MYL fell 0 8

Why Teva Pharmaceutical Industries, Tivity Health, and Marine Products Slumped Today

12/10/18
Wall Street went through another session of extreme volatility on Monday Having fallen nearly 2 at earlier points in the day the broad based S amp P 500 index finished fairly close to unchanged with key sectors like technology helping to provide support to the overall market

After Hours Most Active for Dec 10, 2018 : V, MCHI, MRK, T, WEN, WFC, QQQ, TEVA, MGM, SIRI, AAPL, ODP

12/10/18
The NASDAQ 100 After Hours Indicator is up 8 76 to 6 691 5 The total After hours volume is currently 62 253 799 shares traded The following are the most active stocks for the after hours session Visa Inc V is 0 44 at 138 32 with 5 993 303 shares traded As

Teva Pharmaceutical Industries Enters Oversold Territory (TEVA)

12/10/18
Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on

ACWX, NTES, BAP, TEVA: Large Inflows Detected at ETF

12/07/18
Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares MSCI ACWI ex U S ETF Symbol ACWX where we have detected an approximate 328 7 million dollar inflow that s a 9 8 increase week over week in

Roche's Kadcyla Halves Death Risk in Breast Cancer Study

12/06/18
Roche RHHBY announced that its breast cancer drug Kadcyla significantly reduced the risk of disease recurrence by 50 as adjuvant after surgery therapy in phase III KATHERINE study compared to its other breast cancer drug Herceptin The late stage KATHERINE study compared Kadcyla to

Mylan Expands Recall of Valsartan to All Unexpired Lots

12/05/18
Mylan N V MYL expanded its voluntary recall of blood pressure medicine Valsartan based products in the United States to include all lots of Valsartan containing products which have not expired Late last month the company had announced a recall of selected lots The company is